$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Ion Beam Applications in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $17.96.
The current consensus among 0 contributing investment analysts is to n/a stock in Ion Beam Applications. This rating has held steady since January 2021, when it changed from a Sell consensus rating.
Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. It offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or single photon emission computed tomography radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides measurement and quality assurance instruments for radiotherapy and medical imaging to enable healthcare professionals to verify that equipment administers the planned dose to the targeted area. The company has a strategic alliance with RaySearch Laboratories AB for the advancement of adaptive proton therapy. Ion Beam Applications SA was founded in 1986 and is headquartered in Louvain-la-Neuve, Belgium.
Read More
